tradingkey.logo

Check Cap Ltd

CHEK
1.610USD
0.000
收盤 12/19, 16:00美東報價延遲15分鐘
9.42M總市值
虧損本益比TTM

Check Cap Ltd

1.610
0.000

關於 Check Cap Ltd 公司

Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.

Check Cap Ltd簡介

公司代碼CHEK
公司名稱Check Cap Ltd
上市日期Feb 19, 2015
CEOOvadia (Alex)
員工數量- -
證券類型Ordinary Share
年結日Feb 19
公司地址29 Abba Hushi Ave.
城市
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Israel
郵編3009000
電話97248303401
網址https://check-cap.com/
公司代碼CHEK
上市日期Feb 19, 2015
CEOOvadia (Alex)

Check Cap Ltd公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Boaz Shpigelman
Mr. Boaz Shpigelman
Vice President - Research and Development
Vice President - Research and Development
1.23K
+1.49%
Mr. XiangQian (XQ) Lin
Mr. XiangQian (XQ) Lin
Independent Director
Independent Director
950.00
--
Mr. Alex Ovadia
Mr. Alex Ovadia
Chief Executive Officer
Chief Executive Officer
752.00
--
Ms. Clara Ezed
Ms. Clara Ezed
Independent Director
Independent Director
211.00
--
Mr. Steven J. Hanley
Mr. Steven J. Hanley
Chairman of the Board
Chairman of the Board
--
--
Dr. Yoav Kimchy, Ph.D.
Dr. Yoav Kimchy, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Israel Hershko
Mr. Israel Hershko
Vice President - Quality Assurance and Regulatory Affairs
Vice President - Quality Assurance and Regulatory Affairs
--
--
Mr. Yuval Yanai
Mr. Yuval Yanai
Independent Director
Independent Director
--
--
Dr. Hanit Brenner-lavie
Dr. Hanit Brenner-lavie
Vice President - Clinical Affairs
Vice President - Clinical Affairs
--
--
Mr. Dan Hilerowitz
Mr. Dan Hilerowitz
Chief Financial Officer
Chief Financial Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Boaz Shpigelman
Mr. Boaz Shpigelman
Vice President - Research and Development
Vice President - Research and Development
1.23K
+1.49%
Mr. XiangQian (XQ) Lin
Mr. XiangQian (XQ) Lin
Independent Director
Independent Director
950.00
--
Mr. Alex Ovadia
Mr. Alex Ovadia
Chief Executive Officer
Chief Executive Officer
752.00
--
Ms. Clara Ezed
Ms. Clara Ezed
Independent Director
Independent Director
211.00
--
Mr. Steven J. Hanley
Mr. Steven J. Hanley
Chairman of the Board
Chairman of the Board
--
--
Dr. Yoav Kimchy, Ph.D.
Dr. Yoav Kimchy, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--

收入明細

由於公司未披露,未能獲取相關數據
由於公司未披露,未能獲取相關數據
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
EquityLine Alternate Assets GP Inc
10.86%
Ramanathan (Vijay)
5.13%
Symetryx Corp
4.82%
BNP Paribas Securities Corp. North America
0.31%
Dimensional Fund Advisors, L.P.
0.13%
其他
78.75%
持股股東
持股股東
佔比
EquityLine Alternate Assets GP Inc
10.86%
Ramanathan (Vijay)
5.13%
Symetryx Corp
4.82%
BNP Paribas Securities Corp. North America
0.31%
Dimensional Fund Advisors, L.P.
0.13%
其他
78.75%
股東類型
持股股東
佔比
Corporation
15.69%
Individual Investor
5.13%
Research Firm
0.42%
Investment Advisor/Hedge Fund
0.17%
Bank and Trust
0.05%
Investment Advisor
0.02%
其他
78.53%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
31
46.22K
2.97%
--
2025Q3
31
46.22K
2.97%
-83.61K
2025Q2
30
129.91K
3.13%
+25.59K
2025Q1
31
104.32K
4.46%
-156.41K
2024Q4
32
147.67K
2.55%
+134.65K
2024Q3
33
13.02K
3.40%
+4.10K
2024Q2
36
9.37K
3.50%
-1.09K
2024Q1
41
13.66K
3.76%
-206.06K
2023Q4
43
68.48K
6.43%
+25.25K
2023Q3
45
28.34K
6.39%
+11.71K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
EquityLine Alternate Assets GP Inc
762.72K
10.86%
--
--
Dec 31, 2024
Ramanathan (Vijay)
360.00K
5.13%
--
--
Dec 31, 2024
Symetryx Corp
338.63K
4.82%
--
--
Dec 31, 2024
BNP Paribas Securities Corp. North America
20.14K
0.29%
+300.00
+1.51%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
8.96K
0.13%
--
--
Apr 30, 2025
Morgan Stanley & Co. LLC
4.00K
0.06%
+100.00
+2.56%
Jun 30, 2025
National Bank of Canada
3.27K
0.05%
+3.27K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
2.93K
0.04%
--
--
Aug 31, 2025
J.P. Morgan Securities LLC
1.71K
0.02%
-33.65K
-95.16%
Jun 30, 2025
Independent Financial Partners
500.00
0.01%
--
--
Jun 30, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
公告日期
類型
比率
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1

常見問題

Check Cap Ltd的前五大股東是誰?

Check Cap Ltd的前五大股東如下:
EquityLine Alternate Assets GP Inc
持有股份:762.72K
佔總股份比例:10.86%。
Ramanathan (Vijay)
持有股份:360.00K
佔總股份比例:5.13%。
Symetryx Corp
持有股份:338.63K
佔總股份比例:4.82%。
BNP Paribas Securities Corp. North America
持有股份:20.14K
佔總股份比例:0.29%。
Dimensional Fund Advisors, L.P.
持有股份:8.96K
佔總股份比例:0.13%。

Check Cap Ltd的前三大股東類型是什麼?

Check Cap Ltd 的前三大股東類型分別是:
EquityLine Alternate Assets GP Inc
Ramanathan (Vijay)
Symetryx Corp

有多少機構持有Check Cap Ltd(CHEK)的股份?

截至2025Q4,共有31家機構持有Check Cap Ltd的股份,合計持有的股份價值約為46.22K,占公司總股份的2.97% 。與2025Q3相比,機構持股有所增加,增幅為--。

哪個業務部門對Check Cap Ltd的收入貢獻最大?

在--,--業務部門對Check Cap Ltd的收入貢獻最大,創收--,占總收入的--% 。
KeyAI